- Home
- AVD vs SCPH Comparison
AVD vs SCPH Comparison
Compare AVD & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVD
- SCPH
- Stock Information
- Founded
- AVD 1969
- SCPH 2013
- Country
- AVD United States
- SCPH United States
- Employees
- AVD N/A
- SCPH N/A
- Industry
- AVD Agricultural Chemicals
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- AVD Industrials
- SCPH Health Care
- Exchange
- AVD Nasdaq
- SCPH Nasdaq
- Market Cap
- AVD 158.9M
- SCPH 299.0M
- IPO Year
- AVD N/A
- SCPH 2017
- Fundamental
- Price
- AVD $5.61
- SCPH $5.63
- Analyst Decision
- AVD Strong Buy
- SCPH Buy
- Analyst Count
- AVD 1
- SCPH 3
- Target Price
- AVD $12.00
- SCPH $12.00
- AVG Volume (30 Days)
- AVD 156.7K
- SCPH 2.4M
- Earning Date
- AVD 11-10-2025
- SCPH 11-12-2025
- Dividend Yield
- AVD N/A
- SCPH N/A
- EPS Growth
- AVD N/A
- SCPH N/A
- EPS
- AVD N/A
- SCPH N/A
- Revenue
- AVD $529,067,000.00
- SCPH $49,969,000.00
- Revenue This Year
- AVD N/A
- SCPH $104.30
- Revenue Next Year
- AVD $3.54
- SCPH $76.06
- P/E Ratio
- AVD N/A
- SCPH N/A
- Revenue Growth
- AVD N/A
- SCPH 107.79
- 52 Week Low
- AVD $3.28
- SCPH $1.94
- 52 Week High
- AVD $6.68
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- AVD 61.69
- SCPH 63.97
- Support Level
- AVD $5.41
- SCPH $4.33
- Resistance Level
- AVD $5.73
- SCPH $5.62
- Average True Range (ATR)
- AVD 0.24
- SCPH 0.04
- MACD
- AVD -0.03
- SCPH -0.01
- Stochastic Oscillator
- AVD 63.02
- SCPH 86.67
About AVD American Vanguard Corporation ($0.10 Par Value)
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.